Ibuprofen Concern Has Little Effect On UK Generic OTC Sales
Prices Continue To Rise, According To WaveData
Despite claims last week that ibuprofen worsened the effects of the coronavirus, prices of generic OTC versions of the drug have continued to rise in the UK, reflecting increased demand, according to market analysts WaveData.
You may also be interested in...
Average UK trade prices for paracetamol more than trebled in March as the coronavirus outbreak took hold, while the antiviral valaciclovir saw an average increase of over 300%.
European consumers are increasingly turning towards self-care options, research by Stada Arzneimittel shows. Especially in the areas of stress, sleep and mental health, they are seeking out alternatives to conventional medicine, such as dietary supplements, and support from new health technologies, like digital health apps.
In this episode, HBW Insight talks to regulatory expert Mihai Inceu about the challenges of innovating in Europe’s thriving food supplements market. Senior regulatory affairs officer at consultancy firm Jensen R+, Inceu highlights some of the issues companies face in putting new wellness products onto the European market, particularly if they want to make health claims for herbal ingredients, also known as botanicals. As well as giving good advice about how to avoid getting into trouble with regulators, Inceu also points to some of the latest trends in this dynamic consumer health space.